Skip to content

Randomized, Controlled, Split-Face study to evaluate Adjuvant Efficacy of Topical Antioxidant Combinations Following Lasers for Skin Pigmentation

Randomized, Controlled, Split-Face study to evaluate Adjuvant Efficacy of Topical Antioxidant Combinations Following Lasers for Skin Pigmentation

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0011094
Enrollment
30
Registered
2025-11-04
Start date
2025-04-08
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Others(The multi-antioxidant product contains a combination of vitamins C, E, and ferulic acid.) : A total of 30 participants with pigmentation phenotypes will undergo two sessions of Picosecond Nd:YA

Sponsors

Yonsei University Yongin Severance Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Healthy males or females aged 20 to 65 years who do not meet any exclusion criteria Clinically diagnosed with pigmentation phenotypes with an expected improvement from laser treatment Available for follow-up throughout the study period Able to understand the study, provide written informed consent during the screening visit, and comply with study procedures

Exclusion criteria

Exclusion criteria: Exclusion Criteria: Individuals with infectious skin diseases Individuals with a history of skin diseases at the treatment area other than decreased elasticity, wrinkles, or hyperpigmentation Individuals with keloid tendencies or collagen/elastin fiber disorders Individuals with psychiatric disorders Individuals at risk of bleeding due to anticoagulant medication Individuals with allergies to local anesthetics (e.g., lidocaine) Pregnant or breastfeeding women, or women who may become pregnant Individuals with acute or chronic medical conditions that may affect the outcome of the study Individuals who have undergone filler injections or fat grafting procedures within the last 3 months Individuals who have used topical steroids for more than 2 weeks for the treatment of skin conditions Individuals who have used systemic anti-inflammatory drugs (e.g., corticosteroids) within 4 weeks prior to screening Individuals who have used topical steroids or anti-inflammatory agents within 3 months prior to screening Individuals who have used topical retinol within 4 weeks prior to screening Individuals with a history of cosmetic laser treatments, chemical peels, or plastic surgery on the face within 6 months prior to screening Individuals deemed unsuitable for the clinical trial by the investigator Individuals who are unable to understand the purpose of the study or comply with study requirements

Design outcomes

Primary

MeasureTime frame
Global Aesthetic Improvement Scale (GAIS)

Secondary

MeasureTime frame
Objective skin improvement via Mexameter, Corneometer, Elastometer, and Skin Cube measurements;Clinical photography and image analysis using Mark Vu™ for hemi-MASI and Modified Griffith Scale scoring;Subjective satisfaction surveys from participants

Countries

Korea, Republic of

Contacts

Public Contactjihee kim

Yonsei University Yongin Severance Hospital

mygirljihee@gmail.com+82-31-5189-8778

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026